189 related articles for article (PubMed ID: 17546241)
1. [Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study].
Maia FF; Melo FJ; Araújo IM; Araújo LR
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):426-30. PubMed ID: 17546241
[TBL] [Abstract][Full Text] [Related]
2. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
3. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.
Sharplin P; Gordon J; Peters JR; Tetlow AP; Longman AJ; McEwan P
Cardiovasc Diabetol; 2009 Jan; 8():3. PubMed ID: 19152692
[TBL] [Abstract][Full Text] [Related]
4. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
[TBL] [Abstract][Full Text] [Related]
6. Comparison of insulin glargine versus NPH insulin in people with Type 2 diabetes mellitus under outpatient-clinic conditions for 18 months using a basal-bolus regimen with a rapid-acting insulin analogue as mealtime insulin.
Siegmund T; Weber S; Blankenfeld H; Oeffner A; Schumm-Draeger PM
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):349-53. PubMed ID: 17701878
[TBL] [Abstract][Full Text] [Related]
7. [Use of insulin glargine in type 1 diabetes children with less than eight years old].
Rollin G; Punales M; Geremia C; Ce GV; Tschiedel B
Arq Bras Endocrinol Metabol; 2009 Aug; 53(6):721-5. PubMed ID: 19893914
[TBL] [Abstract][Full Text] [Related]
8. Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.
Garg SK; Paul JM; Karsten JI; Menditto L; Gottlieb PA
Diabetes Technol Ther; 2004 Oct; 6(5):589-95. PubMed ID: 15628812
[TBL] [Abstract][Full Text] [Related]
9. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
Rosenstock J; Park G; Zimmerman J;
Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
[TBL] [Abstract][Full Text] [Related]
10. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
Johansen OE; Vanberg PJ; Kilhovd BK; Jørgensen AP
Vasc Health Risk Manag; 2009; 5(1):121-8. PubMed ID: 19436668
[TBL] [Abstract][Full Text] [Related]
11. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.
Chase HP; Arslanian S; White NH; Tamborlane WV
J Pediatr; 2008 Oct; 153(4):547-53. PubMed ID: 18589448
[TBL] [Abstract][Full Text] [Related]
12. Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.
Toyoda M; Kimura M; Yamamoto N; Miyauchi M; Umezono T; Suzuki D
J Nephrol; 2012; 25(6):989-95. PubMed ID: 22307438
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.
Pan CY; Sinnassamy P; Chung KD; Kim KW;
Diabetes Res Clin Pract; 2007 Apr; 76(1):111-8. PubMed ID: 17011662
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].
Pesić M; Zivić S; Radenković S; Velojić M; Dimić D; Antić S
Vojnosanit Pregl; 2007 Apr; 64(4):247-52. PubMed ID: 17580534
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.
Haukka J; Hoti F; Erästö P; Saukkonen T; Mäkimattila S; Korhonen P
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1326-35. PubMed ID: 24150837
[TBL] [Abstract][Full Text] [Related]
16. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.
Ashwell SG; Bradley C; Stephens JW; Witthaus E; Home PD
Diabetes Care; 2008 Jun; 31(6):1112-7. PubMed ID: 18339977
[TBL] [Abstract][Full Text] [Related]
17. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
Chatterjee S; Jarvis-Kay J; Rengarajan T; Lawrence IG; McNally PG; Davies MJ
Diabetes Res Clin Pract; 2007 Aug; 77(2):215-22. PubMed ID: 17141354
[TBL] [Abstract][Full Text] [Related]
18. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
Alemzadeh R; Berhe T; Wyatt DT
Pediatrics; 2005 May; 115(5):1320-4. PubMed ID: 15867042
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
[No Abstract] [Full Text] [Related]
20. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
